{{Drugbox
| IUPAC_name = 3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-6-chloro-1''H''-benzimidazol-2-one
| image = Clopimozide.svg
| width = 270

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 53179-12-7
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 65449
| ChEMBL = 2104161
| ChemSpiderID = 58909
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7C6TA32SD2
| KEGG = D02649

<!--Chemical data-->
| C=28 | H=28 | Cl=1 | F=2 | N=3 | O=1
| molecular_weight = 495.99 g/mol
| smiles = Fc1ccc(cc1)C(c2ccc(F)cc2)CCCN5CCC(N4c3ccc(Cl)cc3NC4=O)CC5
}}

'''Clopimozide''' ('''R-29,764''') is a [[typical antipsychotic]] [[drug]] of the [[diphenylbutylpiperidine]] class.<ref name="pmid37697">{{cite journal | vauthors = De Cuyper HJ, Van Praag HM, Mulder WR | title = Therapeutical significance of clopimozide in the treatment of chronic psychotic patients | journal = Acta Psychiatrica Scandinavica | volume = 59 | issue = 5 | pages = 561–74 |date=May 1979 | pmid = 37697 | doi = 10.1111/j.1600-0447.1979.tb00256.x| url = }}</ref><ref name="pmid798469">{{cite journal | vauthors = Knapen J, Bollen J, Brugmanns J, Rombaut N | title = [Treatment of chronic psychoses with oral clopimozide] | language = French | journal = Acta Psychiatrica Belgica | volume = 76 | issue = 4 | pages = 644–57 | year = 1976 | pmid = 798469 | doi = | url = }}</ref> It is very [[Potency (pharmacology)|potent]] and has an extremely long duration of action, lasting at least one week with a single dose.<ref name="pmid1242360">{{cite journal | vauthors = Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Wauquier A | title = Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series | journal = Arzneimittel-Forschung | volume = 25 | issue = 8 | pages = 1287–94 |date=August 1975 | pmid = 1242360 | doi = | url = }}</ref><ref name="pmid25071">{{cite journal | vauthors = Floru L, Tegeler J | title = Clinical experiments with the new oral long-acting neuroleptic clopimozide (R 29 764) | journal = Arzneimittel-Forschung | volume = 28 | issue = 2 | pages = 341–4 | year = 1978 | pmid = 25071 | doi = | url = }}</ref><ref name="pmid970182">{{cite journal | vauthors = Bobon J, Parent M, Toussaint C, Pinchard A | title = [Long-acting neuroleptics. IV. Preliminary study of clopimozide (R 29764)] | language = French | journal = Acta Psychiatrica Belgica | volume = 76 | issue = 1 | pages = 138–43 | year = 1976 | pmid = 970182 | doi = | url = }}</ref> It was developed by [[Janssen Pharmaceutica]] but was never marketed.

== See also ==
* [[Typical antipsychotic]]
* [[Diphenylbutylpiperidine]]

== References ==
{{reflist}}

{{Antipsychotics}}
{{Cholinergics}}
{{Dopaminergics}}
{{Histaminergics}}
{{Serotonergics}}

[[Category:Benzimidazoles]]
[[Category:Chloroarenes]]
[[Category:Diphenylbutylpiperidines]]
[[Category:Fluoroarenes]]
[[Category:Ureas]]
[[Category:Typical antipsychotics]]


{{nervous-system-drug-stub}}